Zivo Bioscience Inc (ZIVO)
7.98
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Zivo Bioscience 1 Year Total Returns (Daily): -55.22% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -55.22% |
May 16, 2024 | -53.82% |
May 15, 2024 | -56.57% |
May 14, 2024 | -57.35% |
May 13, 2024 | -57.35% |
May 10, 2024 | -58.83% |
May 09, 2024 | -62.93% |
May 08, 2024 | -53.52% |
May 07, 2024 | -55.04% |
May 06, 2024 | -52.64% |
May 03, 2024 | -53.96% |
May 02, 2024 | -53.02% |
May 01, 2024 | -53.31% |
April 30, 2024 | -55.22% |
April 29, 2024 | -62.87% |
April 26, 2024 | -52.38% |
April 25, 2024 | -53.05% |
April 24, 2024 | -54.49% |
April 23, 2024 | -55.11% |
April 22, 2024 | -55.11% |
April 19, 2024 | -55.01% |
April 18, 2024 | -56.71% |
April 17, 2024 | -60.75% |
April 16, 2024 | -61.13% |
April 15, 2024 | -54.34% |
Date | Value |
---|---|
April 12, 2024 | -54.57% |
April 11, 2024 | -55.26% |
April 10, 2024 | -56.28% |
April 09, 2024 | -56.43% |
April 08, 2024 | -56.43% |
April 05, 2024 | -56.34% |
April 04, 2024 | -60.95% |
April 03, 2024 | -57.09% |
April 02, 2024 | -59.42% |
April 01, 2024 | -59.42% |
March 28, 2024 | -53.70% |
March 27, 2024 | -53.23% |
March 26, 2024 | -47.51% |
March 25, 2024 | -46.93% |
March 22, 2024 | -53.48% |
March 21, 2024 | -53.44% |
March 20, 2024 | -55.05% |
March 19, 2024 | -55.45% |
March 18, 2024 | -55.45% |
March 15, 2024 | -51.58% |
March 14, 2024 | -54.78% |
March 13, 2024 | -56.21% |
March 12, 2024 | -55.26% |
March 11, 2024 | -53.44% |
March 08, 2024 | -56.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.97%
Minimum
Nov 28 2023
112.7%
Maximum
Oct 29 2020
-24.50%
Average
-24.81%
Median
Oct 19 2022
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -83.53% |
Palatin Technologies Inc | -18.03% |
iBio Inc | -89.71% |
Theriva Biologics Inc | -47.04% |
Oragenics Inc | -21.02% |